BIOTECH GROWTH N V

Average Profitability
<0.0001%
Insider Buys Quantity
12
Insider Buys Sum
$27.2M
Insider Sells Quantity
1
Insider Sells Sum
$12.02M

Insider Activity of BIOTECH GROWTH N V

According to the SEC Form 4 filings, BIOTECH GROWTH N V, being in a position of

  1. 10 percent owner at ESSA Pharma Inc.,
    оver the last 12 months, has bought 0 shares, and sold 7879583 shares for $12.02M,
    over all time since 2021-08-18, has bought 2250000 shares for $10.44M, and sold 7879583 shares for $12.02M.

The largest purchase of all time was on 2023-06-27 and amounted to 1740000 shares of Black Diamond Therapeutics, Inc. for $9.56M.

The largest sale of all time was on 2024-11-01 and amounted to 7879583 shares of ESSA Pharma Inc. for $12.02M.

Biography of BIOTECH GROWTH N V

No biography is available at this moment.

2024-11-01SaleESSA Pharma Inc.
EPIX
10 percent owner
7.88M
19.3487%
$1.53$12.02M+16.43%
2023-10-17PurchaseBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
400,000
0.7707%
$2.34$934,080+99.57%
2023-06-30PurchaseBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
1M
2.7138%
$5.00$5M-28.71%
2023-06-27PurchaseBlack Diamond Therapeutics, Inc.
BDTX
10 percent owner
1.74M
4.2378%
$5.49$9.56M-41.59%
2022-10-31PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
99,801
0.268%
$2.25$224,912-6.28%
2022-10-28PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
172,974
0.4696%
$2.18$376,962-1.81%
2022-10-27PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
191,678
0.5124%
$1.87$359,224+12.69%
2022-10-27PurchaseESSA Pharma Inc.
EPIX
director
500,000
1.1742%
$4.50$2.25M-32.41%
2022-10-26PurchaseESSA Pharma Inc.
EPIX
director
1.5M
2.8096%
$3.98$5.97M-39%
2022-10-21PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
87,850
0.2313%
$1.51$132,750+37.97%
2022-10-20PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
53,734
0.144%
$1.42$76,345+48.97%
2022-10-19PurchaseBlack Diamond Therapeutics, Inc.
BDTX
director
77,689
0.2096%
$1.32$102,775+61.48%
2021-08-18PurchaseESSA Pharma Inc.
EPIX
10 percent owner
250,000
0.6078%
$8.88$2.22M-9.55%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.